Market closedNon-fractional

ArriVent BioPharma/AVBP

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About ArriVent BioPharma

ArriVent BioPharma Inc is a clinical stage biopharmaceutical company dedicated to the identification, development and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize team's deep drug development experience to maximize the potential of lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.

Ticker

AVBP

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Newtown Square, United States

Employees

40

AVBP Metrics

BasicAdvanced
$612M
Market cap
-
P/E ratio
-$9.23
EPS
-
Beta
-
Dividend rate
$612M
32.823
31.9
0.043
0.09
-30.30%
1.95
1.95
-2.564
-71.69%

What the Analysts think about AVBP

Analyst Ratings

Majority rating from 5 analysts.
Buy

AVBP Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
0.00% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
NaN%
Net income
-$17M
-17.54%
Profit margin
0.00%
NaN%

AVBP Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 36.20%
QuarterlyAnnual
Q1 24
Q2 24
Actual
-$0.70
-
Expected
-$1.10
-$0.66
Surprise
-36.20%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for ArriVent BioPharma stock?

ArriVent BioPharma (AVBP) has a market cap of $612M as of July 05, 2024.

What is the P/E ratio for ArriVent BioPharma stock?

The price to earnings (P/E) ratio for ArriVent BioPharma (AVBP) stock is 0 as of July 05, 2024.

Does ArriVent BioPharma stock pay dividends?

No, ArriVent BioPharma (AVBP) stock does not pay dividends to its shareholders as of July 05, 2024.

When is the next ArriVent BioPharma dividend payment date?

ArriVent BioPharma (AVBP) stock does not pay dividends to its shareholders.

What is the beta indicator for ArriVent BioPharma?

ArriVent BioPharma (AVBP) does not currently have a Beta indicator.

Buy or sell ArriVent BioPharma stock

Buy or sell ArriVent BioPharma stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing